Skip to main content

Table 1 Selected characteristics of the study population at blood collection (n cases/controls =1558/1558)

From: Circulating inflammatory biomarkers, adipokines and breast cancer risk—a case-control study nested within the EPIC cohort

Variables

Cases

Controls

Mean (SD) or N (%)

Mean (SD) or N (%)

Breast cancer cases characteristics

Time between blood collection and diagnosis in years

8.6 (2.8)

Age at diagnosis in years

61.4 (8.3)

ER positive

  Negative

305 (19.6)

  Positive

1253 (80.4)

PR status

  

  Negative

509 (31.8)

  Positive

1104 (68.2)

HER2 status

  Negative

1224 (78.6)

  Positive

334 (21.4)

Molecular status

  ER+PR±HER2+

210 (13.7)

  ER+PR±HER2−

1043 (68.3)

  ER−PR−HER2−

160 (10.5)

  ER−PR−HER2+

115 (7.5)

Sociodemographic, lifestyle and reproductive factors

Age at blood collection in years

52.5 (7.9)

52.5 (7.9)

Education level (N missing=63)

 

  Primary/no schooling

557 (37)

571 (37)

  Technical/professional/secondary

647 (42)

638 (42)

  Longer education

324 (21)

316 (21)

Time since last meal at blood collection in hours (N missing=49)

  < 3 h

706 (46)

712 (46)

  ≥ 3–≤ 6 h

273 (18)

272 (18)

  > 6 h

552 (36)

552 (36)

Physical activity index (N missing=27)

  Inactive

349 (23)

312 (20)

  Moderately inactive

573 (37)

610 (40)

  Moderately active

346 (22)

335 (22)

  Active

282 (18)

282 (18)

Smoking status (N missing=25)

  Never

875 (56)

875 (56)

  Former

351 (23)

334 (22)

  Smoker

319 (22)

337 (22)

Alcohol consumption at recruitment in g/day (N missing=4)

  Non drinker

223 (14)

220 (14)

  > 0–≤ 3

459 (29)

423 (27)

  > 3–≤ 12

454 (29)

434 (28)

  > 12–≤ 24

256 (16)

270 (17)

  > 24

166 (11)

207 (13)

Age at first menstrual period in years (N missing=32)

  ≤ 13

977 (63)

961 (62)

  > 13

568 (37)

578 (38)

Number of full-term pregnancies and age at first full-term pregnancy* (N missing=91)

  Nulliparous

243 (16)

213 (14)

  Age <30 (1-2 children)

714 (47)

739 (47)

  Age <30 (≥3 children)

340 (22)

385 (25)

  Age ≥30

215 (14)

176 (11)

Ever breastfed among women with full-term pregnancy

  No

199 (15)

188 (14)

  Yes

1034 (80)

1,069 (80)

  Missing

68 (5)

77 (6)

Use of exogenous hormones at blood collection

489 (31.4)

489 (31.4)

Ever use of oral contraceptive at baseline (N missing=11)

939 (50.5)

919 (49.5)

Ever use of menopausal hormone therapy at baseline among postmenopausal women (N missing=5)

415 (49.7)

420 (50.3)

Menopausal status at blood collection (N missing=0)

  Premenopausal

413 (26)

413 (26)

  Perimenopausal

307 (20)

307 (20)

  Postmenopausal

838 (54)

838 (54)

Anthropometric factors

Weight in kg

  Among premenopausal women

64.5 (10.7)

64.8 (11.2)

  Among perimenopausal women

67.9 (12.3)

66.8 (10.4)

  Among postmenopausal women

69.1 (12.6)

66.8 (10.9)

Height in cm

  Among premenopausal women

161.9 (6.5)

162.1 (6.6)

  Among perimenopausal women

162.6 (6.6)

161.8 (6.8)

  Among postmenopausal women

162.1 (6.6)

161.2 (6.5)

Body mass index in kg/m2

  Among premenopausal women

24.7 (4.2)

24.7 (4.1)

  Among perimenopausal women

25.7 (4.6)

25.6 (4.0)

  Among postmenopausal women

26.3 (4.7)

25.7 (4.1)

Waist circumference in cm (N missing=78)

  Among premenopausal women

77.8 (10.2)

78.0 (10.2)

  Among perimenopausal women

81.8 (11.3)

80.3 (11.1)

  Among postmenopausal women

83.3 (11.7)

81.5 (10.2)

Hip circumference in cm (N missing= 78)

  Among premenopausal women

99.4 (8.2)

99.9 (8.4)

  Among perimenopausal women

102.0 (9.1)

101.3 (8.3)

  Among postmenopausal women

103.3 (9.5)

101.3 (8.0)

Waist to hip ratio (N missing= 78)

  Among premenopausal women

0.78 (0.06)

0.78 (0.06)

  Among perimenopausal women

0.80 (0.07)

0.79 (0.09)

  Among postmenopausal women

0.81 (0.07)

0.80 (0.07)

Comorbidities

History of diabetes (N missing=60)

40 (3)

22 (1)

History of hypertension

  No

1078 (35)

1094 (35)

  Yes

354 (11)

323 (10)

  Missing

126 (4)

141 (5)

  1. Abbreviations: ER, oestrogen receptor; HER2, human epidermal growth factor 2; PR, progesterone receptor; SD, standard deviation.
  2. Note: Controls were matched to cases on the centre of recruitment, age, menopausal status at blood collection, phase of the menstrual cycle for premenopausal women, use of exogenous hormone at blood collection, time of the day, and fasting status at blood collection